These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4953095

  • 1. Drugs and uric acid.
    Rundles RW, Wyngaarden JB.
    Annu Rev Pharmacol; 1969; 9():345-62. PubMed ID: 4953095
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of allopurinol on the metabolism of uric acid].
    Swiderska-Kulikowa B, Jelińska S.
    Pol Arch Med Wewn; 1973 Apr; 50(4):391-8. PubMed ID: 4574007
    [No Abstract] [Full Text] [Related]

  • 3. Selected aspects of the aetiology, pathogenesis and treatment of disorders of purine metabolism.
    Boyle JA, Seegmiller JE.
    Mod Trends Rheumatol; 1971 Apr; 2():299-322. PubMed ID: 4949589
    [No Abstract] [Full Text] [Related]

  • 4. The Jewish Hospital of St. Louis. Therapeutic grand rounds number 7. An approach to disorders of uric acid metabolism.
    Thier SO, Wessler S, Avioli LV.
    Arch Intern Med; 1974 Sep; 134(3):579-85. PubMed ID: 4855167
    [No Abstract] [Full Text] [Related]

  • 5. Depletion of erythrocyte phosphoribosylpyrophosphate in man.
    Fox IH, Wyngaarden JB, Kelley WN.
    N Engl J Med; 1970 Nov 26; 283(22):1177-82. PubMed ID: 4319625
    [No Abstract] [Full Text] [Related]

  • 6. A comparative study of the xanthine oxidase inhibitors allopurinol and oxipurinol in man.
    Chalmers RA, Krömer H, Scott JT, Watts RW.
    Clin Sci; 1968 Oct 26; 35(2):353-62. PubMed ID: 5721238
    [No Abstract] [Full Text] [Related]

  • 7. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E, Schwarczmann P.
    Munch Med Wochenschr; 1969 Aug 08; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract] [Full Text] [Related]

  • 8. A quantitative study of skeletal-muscle purines and pyrazolo(3,4-d)pyrimidines in gout patients treated with allopurinol.
    Watts RW, Snedden W, Parker RA.
    Clin Sci; 1971 Aug 08; 41(2):153-8. PubMed ID: 5564305
    [No Abstract] [Full Text] [Related]

  • 9. [Fundamentals of gout research (author's transl)].
    Zöllner N.
    MMW Munch Med Wochenschr; 1974 Apr 26; 116(17):865-74. PubMed ID: 4210712
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R, Vindel J, Lamarche M, Kissel P.
    Presse Med (1893); 1968 Dec 14; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract] [Full Text] [Related]

  • 12. The physiologic approach to hyperuricemia.
    Rastegar A, Thier SO.
    N Engl J Med; 1972 Mar 02; 286(9):470-6. PubMed ID: 4550616
    [No Abstract] [Full Text] [Related]

  • 13. Basic sciences in medicine: the example of gout.
    Stetten D.
    N Engl J Med; 1968 Jun 13; 278(24):1333-6. PubMed ID: 5648600
    [No Abstract] [Full Text] [Related]

  • 14. Allopurinol. A review.
    Frayha RA.
    J Med Liban; 1971 Jun 13; 24(5):463-71. PubMed ID: 4948390
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of hyperuricemia].
    Ryckewaert A.
    Presse Med (1893); 1968 Dec 14; 76(49):2319-22. PubMed ID: 5260909
    [No Abstract] [Full Text] [Related]

  • 16. [The effect of daily single doses of 300 mg allopurinol on serum uric acid concentration and urate excretion in gouty patients (author's transl)].
    Matzkies F, Berg G.
    Dtsch Med Wochenschr; 1974 Nov 29; 99(48):2464-5. PubMed ID: 4448143
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of gouty purine metabolism disorder with mercapto-pyrazolo-pyrimidine (thiopurinol)].
    Delbarre F, Auscher C, de Gery A, Brouilhet H, Olivier JL.
    Presse Med (1893); 1968 Dec 14; 76(49):2329. PubMed ID: 5737251
    [No Abstract] [Full Text] [Related]

  • 18. An enzymatic basis for variation in response to allopurinol. Hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Kelley WN, Rosenbloom FM, Miller J, Seegmiller JE.
    N Engl J Med; 1968 Feb 08; 278(6):287-93. PubMed ID: 5638346
    [No Abstract] [Full Text] [Related]

  • 19. The development of allopurinol.
    Rundles RW.
    Arch Intern Med; 1985 Aug 08; 145(8):1492-503. PubMed ID: 3896181
    [No Abstract] [Full Text] [Related]

  • 20. [Current biochemical acquisitions on pathogenesis of gout].
    Marcolongo R.
    Reumatismo; 1971 Aug 08; 23(3):109-25. PubMed ID: 5150688
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.